Amylx Pharmaceuticals Inc vs Fortinet Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Fortinet Inc trades at $161.04 (market cap $118.78B). The key difference: Fortinet Inc is far larger — about 45× Amylx Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMLX | FTNT | |
|---|---|---|
Market Cap | $2.64B | $118.78B |
Sector | Health | Technology |
52-Week High | $24.19 | $168.29 |
52-Week Low | $7.82 | $75.23 |
Enterprise Value | $2.39B | $115.21B |
Trailing returns across standard periods
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →